Nasal mast cell stabilizers inhibit the degranulation of mast cells, thereby inhibiting the release of histamine. These are preventive medications and should be used regularly beginning approximately 2 weeks before exposure. Like corticosteroids, mast cell stabilizers are available as single-ingredient formulations or in combination with corticosteroids, antihistamines, or leukotriene inhibitors. Common adverse effects include hoarseness, cough, and a bitter taste.6
Nasal decongestants activate α-adrenergic receptors in the nasal mucosa, constricting the blood vessels and shrinking swollen tissue. These should only be used for short periods because prolonged use may lead to rebound congestion. Common adverse effects include headache, nervousness, sleep difficulties, and high blood pressure. Patients with hypertension, glaucoma, and prostate enlargement should not take decongestants.7
Finally, leukotriene inhibitors decrease the action or production of leukotrienes, signaling molecules involved in the inflammatory response to an allergen. These medications help reduce inflammation and mucus production and prevent airway constriction. Common adverse effects include nausea, vomiting, and diarrhea.8
IMMUNOTHERAPY
Immunotherapy is a process by which the immune system is trained not to react to certain allergens. This is accomplished by gradually increasing exposure to those allergens. As exposure increases, the immune system becomes less sensitive to the substance. Allergy immunotherapy is available as a series of injections, sublingual tablets, and drops, although sublingual drops are not FDA approved.9
Immunotherapy can be a long-term, effective way to reduce the severity of allergy symptoms and improve quality of life, especially for allergens that cannot be avoided. More than 1 allergen may be treated simultaneously with immunotherapy. Immunotherapy may also decrease the consumption of medications used to treat allergy symptoms.9
Patients may have allergic reactions to immunotherapy, and therefore, all injectable allergens are administered in a physician’s office, as are the first few doses of oral therapy, and patients must be monitored for 30 minutes. Patients may have to wait 6 to 12 months before the benefits are experienced, and therapy usually continues for 3 to 5 years.10
Approximately 80% of patients experience significant symptom improvement, and approximately 60% experience permanent benefits after 3 to 5 years.10
PHARMACISTS’ ROLE
Early diagnosis and proactive management of seasonal allergies can vastly improve patients’ symptoms and quality of life. Many remedies are available to treat mild to severe allergy symptoms in even the patients with the most complex cases.
Pharmacists can explain medication dosages and schedules and provide patients with guidance on which OTC products may work best for them. They can help patients get the most out of their medications by demonstrating how to properly use inhalers, nasal sprays, and eye drops. Pharmacists can also help reduce costs by reducing redundancies and suggesting reliable generic medications, rebate promotions, and drug cards.
CONCLUSION
Spring allergies are a common yet costly occurrence. A wide variety of treatments are available to reduce symptoms and improve quality of life. Allergies are treated with the avoidance of allergens and medications, including corticosteroids, antihistamines, decongestants, mast cell stabilizers, and leukotriene inhibitors. Patients unable to avoid allergens or with severe symptoms may benefit from immunotherapy.
REFERENCES
1. Allergies. CDC. February 1, 2023. Accessed January 20, 2025. https://www.cdc.gov/nchs/fastats/allergies.htm
2. Immune response. MedlinePlus. Updated March 31, 2024. Accessed January 20, 2025. https://medlineplus.gov/ency/article/000821.htm
3. Seasonal allergies: nip them in the bud. Mayo Clinic. February 28, 2024. Accessed January 20, 2025. https://www.mayoclinic.org/diseases-conditions/hay-fever/in-depth/seasonal-allergies/art-20048343
4. Antihistamines for allergies. MedlinePlus. Updated May 20, 2024. Accessed January 20, 2025. https://medlineplus.gov/ency/patientinstructions/000549.htm
5. Corticosteroid (nasal route). Mayo Clinic. Updated August 1, 2024. Accessed January 20, 2025. https://www.mayoclinic.org/drugssupplements/corticosteroid-nasal-route/description/drg-20070513
6. Finn DF, Walsh JJ. Twenty-first century mast cell stabilizers. Br J Pharmacol. 2013;170(1):23-37. doi:10.1111/bph.12138
7. Decongestants. NHS Inform. Updated May 31, 2024. Accessed January 20, 2025. https://www.nhsinform.scot/tests-and-treatments/medicines-and-medical-aids/types-of-medicine/decongestants/
8. Leukotriene antagonists: allergy treatment and side effects. Wyndly.Updated February 17, 2024. Accessed January 20, 2025. https://www.wyndly.com/blogs/learn/leukotriene-antagonists
9. Allergy shots. Mayo Clinic. April 13, 2024. Accessed January 20, 2025. https://www.mayoclinic.org/tests-procedures/allergy-shots/about/pac-20392876
10. Allergy shots. Cleveland Clinic. Updated August 9, 2023. Accessed January 20, 2025. https://my.clevelandclinic.org/health/treatments/25194-allergy-shots